Title: Bellco srl Lynda CRRT machine CVVH PEX
1Bellco srlLynda CRRT machineCVVH PEX
CPFA Presentation
2Versatile for the physician, functional for the
nurse, effective for the patient. A simple answer
to complex questions from the Abyle line
3(No Transcript)
4Therapeutic versatility
Technological innovation, the wide range of
therapies and ease of use are the essential
features of Lynda
5Therapeutic versatility
- Wide range of options
- Continual monitoring of hematocrit and oxygen
saturation - The HCT (with blood volume calculation) and the
SO2 can directly and continuously be measured
through a high-precision instrument (closed
system with cuvette integrated in the arterial
line).
A sensor measures a physical quantity. An
application interprets the measurement and gives
it a clinical meaning
6Therapeutic versatility
- Wide range of options
- Continual monitoring of hematocrit and
oxygen saturation
- Program the infusion system in
- pre-dilution, post-dilution,
- or pre-post dilution simultaneously
7Therapeutic versatility
- Wide range of options
- Continual monitoring of hematocrit and oxygen
saturation
- Program the infusion system in pre-dilution,
post-dilution, or pre-post dilution
simultaneously - Filtration fraction control (ff).
8Therapeutic versatility
- Wide range of options
- Continual monitoring of hematocrit and oxygen
saturation
- Program the infusion system in pre-dilution,
post-dilution, or pre-post dilution
simultaneously - Filtration fraction control (ff).
- History file (over 300 hours capacity).
- The most important information on the therapies
performed, the clinical parameter settings, the
pressure and infused fluid volume graphs
9Functionality
- Automatic priming in all treatment methods.
10Functionality
- Automatic priming in all treatment methods.
- On-line guide for the operator to check all the
sequences instant by instant.
11Functionality
- Automatic priming in all treatment methods.
- On-line guide for the operator to check all the
sequences instant by instant. - High-visibility display with user-friendly
and intuitive touch screen
interface, which
allows clear, fast and direct
dialogue with the
machine.
12Functionality
- Automatic priming in all treatment methods.
- On-line guide for the operator to check all the
sequences instant by instant. - High-visibility display with user-friendly and
intuitive touch screen interface, which allows
clear, fast and direct
dialogue with the machine. - Autonomy of 40 litres of controlled exchange
between two scales, saving
time and reducing
the possibility of error
13Effectiveness
- Bicompartmental bag
- The bag is composed of two separate compartments
one for the bicarbonate buffer (5000 mL) and the
other for the electrolytes (500 mL). The contents
are mixed just before use. - Two simple operations allow obtaining a solution
that remains stable up to 24 hours - - Breakage of the septum separating the two
compartments - Brief agitation to encourage mixing and obtain a
homogeneous solution.
14Effectiveness
- The disposable Plug Play system,
comprising preconnected filter/s and
lines for all the treatment methods, simplifies
and speeds up the installation operations and
reduces the possibility of error.
15SCUF(SLOW CONTINUOUS ULTRAFILTRATION)
Uf
EMOFILTRO
16CVVH, IHF-HVHF(CONTINUOUS VENO-VENOUS
HEMOFILTRATION, INTERMITTENT HEMO FILTRATION
HIGH VOLUME HEMOFILTRATION, SINGLE NEEDLE
HEMOFILTRATION)
Post diluizione (20100)
Uf
EMOFILTRO
Infusione o anticoagulante
Pre diluizione (080)
17SN HF(SINGLE NEEDLE HEMOFILTRATION)
Uf
EMOFILTRO
Infusione o anticoagulante
18 PEX (PLASMA EXCHANGE)
Liquido di sostituzione
Post diluizione
Plasma
PLASMAFILTRO
19CPFA
anticoagulante
20Effectiveness
- Disposable Plug Play
- CPFA a targeted response to sepsis
21What is Sepsis ?ACCP/SCCM Consensus Definitions
- Severe Sepsis
- Sepsis
- Organ dysfunction
- Septic shock
- Sepsis
- Hypotension despite fluid resuscitation
- Multiple Organ Dysfunction Syndrome (MODS)
- Altered organ function in an acutely ill patient
- Homeostasis cannot be maintained without
intervention
- Infection
- Inflammatory response to microorganisms, or
- Invasion of normally sterile tissues
- Systemic Inflammatory Response Syndrome (SIRS)
- Systemic response to a variety of processes
- Sepsis
- Infection plus
- ?2 SIRS criteria
Bone RC et al. Chest. 19921011644-55.
22Therapeutic Strategies
Systemic inflammatory response
Multi-organ dysfunction
Infection
Endothelial Dysfunction
Cell activation
Eliminate infection antibiotics
Reduce systemic reaction Steroids Insulin
(glucose control) Xigris
Support organs Ventilation CRRT
IV fluids Vasopressors
23Coupled Plasma Filtration Adsorption
Plasma
UF out
reinfusion in
24Therapeutic goal
Separate and retain toxins from a complex
mixture
Time 0
later
toxins
Physiologicalgood molecules
25Ideal therapy for sepsis
Plasma
bad molecules
good molecules
Dialysate out
Dialysate in
26What can the CPFA resin adsorb?
- Macrophage inflammatory protein-a (MIP-a)
- Macrophage inflammatory protein-b (MIP-b)
- Tumor necrosis factor-aTNF-a
- Monocyte chemotactic protein (MCP-1)
- RANTES
- Epithelial neutrophil activating peptide 78
(ENA-78) - Angiogenin
- Interleukin 1b
- Interleukin 5
- Interleukin 6
- Interleukin 7
- Interleukin 8
- Interleukin 10(?)
- Interleukin 12p70
- Interleukin 16
- Interleukin 18
27CPFA used successfully in non-ARF patients
Hemodynamic response to coupled
plasmafiltration-adsorption in human septic shock
Marco Formica, Carlo Olivieri, Sergio Livigni,
Giulio Cesano, Antonella Vallero, Mariella Maio
and Ciro Tetta
Intensive Care Med (2003) 29 703-708
Objective The objective was to examine the
effect of repeated applications of coupled
plasmafiltration-adsorption on the hemodynamic
response in septic shock patients hospitalized in
intensive care units (ICUs).
Conclusion Coupled plasmafiltration-adsorption
was a feasible and safe extracorporeal treatment
and exerted a remarkable improvement in the
hemodynamics, the pulmonary function, and the
outcome in septic shock patients with or without
concomitant ARF.
28What is not adsorbed to the resin
- No significant adsorption of
- Albumin
- Heparin
- Citrate
- Antibodies
- Ferritin
- GM-CSF
- Thyroxine
- Adiponectin
- Von Willebrand factor
- Endotoxin
- Low Adsorption
- Insulin (1st hour)
- VEGF
- EGF
- ICAM
- VCAM
- MCP